SummaryRMgm-4855
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene disruption |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 32670896 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Zheng W, Cao Y |
Name Group/Department | Department of Immunology, College of Basic Medical Sciences |
Name Institute | China Medical University |
City | Shenyang |
Country | China |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-4855 |
Principal name | Δpbqsox |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Normal numbers of gametocytes are produced. Whereas, pbqsox deletion did not affect the formation of macrogametes, it reduced the number of exflagellation centers by 28.0%. Ookinetes in the Δpbqsox line retained normal morphology, but the proportion of mature ookinetes (stage IV-VI) was reduced by 43.1%. Consistent with the in vitro ookinete conversion result, the number of ookinetes formed in the blood bolus of mosquitoes feeding on Δpbqsox-infected mice was 60.2–64.6% lower than that with the WT parasites. |
Oocyst | A 61.8–62.8% reduction in oocyst number/midgut in mosquitoes after feeding on Δpbqsox-infected mice as compared to those fed on WT parasite-infected mice. The gross morphology of oocysts appeared normal in the Δpbqsox parasites compared to the WT |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Phenotype
Normal numbers of gametocytes are produced. Whereas, pbqsox deletion did not affect the formation of macrogametes, it reduced the number of exflagellation centers by 28.0%. Ookinetes in the Δpbqsox line retained normal morphology, but the proportion of mature ookinetes (stage IV-VI) was reduced by 43.1%.
Consistent with the in vitro ookinete conversion result, the number of ookinetes formed in the blood bolus of mosquitoes feeding on Δpbqsox-infected mice was 60.2–64.6% lower than that with the WT parasites. A 61.8–62.8% reduction in oocyst number/midgut in mosquitoes after feeding on Δpbqsox-infected mice as compared to those fed on WT parasite-infected mice. The gross morphology of oocysts appeared normal in the Δpbqsox parasites compared to the WT.
Additional information Evidence is presented that: - Recombinant PbQSOX possesses thiol oxidase activity - PbQSOX Is Expressed Primarily in Sexual Stages (gametocytes/ookinetes with higher - PbQSOX Is Secreted and Associated With Plasma Membranes of ookinetes (in gametocytes in cytoplasm). Also expression in sporozoites
- PbQSOX Is Required for Disulfide Bridges of Surface Proteins in Ookinetes Other mutants
|
top of page | |||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1455400 | ||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1242000 | ||||||||||||||||||||||||
Gene product | sulfhydryl oxidase, putative | ||||||||||||||||||||||||
Gene product: Alternative name | Quiescin sulfhydryl oxidase, QSOX | ||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||
Type of plasmid/construct used | (Linear) plasmid double cross-over | ||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||
Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
Additional remarks partial/complete disruption | |||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||
Additional remarks genetic modification | To knock out pbqsox, an 824-bp upstream fragment containing the 5′ UTR was amplified from P. berghei genomic DNA using primers 5UTR-F and 5UTR-R, and cloned in the plasmid PL0034 at the HindIII and PstI sites upstream of the hdhfr cassette. Similarly, an 805-bp downstream fragment containing the 3′ UTR was amplified using primers 3UTR-F and 3UTR-R, and inserted at the XhoI and EcoRI sites downstream of the hdhfr cassette. This would replace the pbqsox protein-coding region with the hdhfr expression cassette which confers resistance to pyrimethamine. The plasmid was linearized by HindIII/EcoRI digestion | ||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||
Primer information: Primers used for amplification of the target sequences
![]() Primer information: Primers used for amplification of the target sequences
![]()
| |||||||||||||||||||||||||
top of page |